SCHEMBL11300774

SCHEMBL11300774

O=C1CC(N(c2ccc(F)cc2)c2ccc(C(=O)NO)cc2)CN1

nearest known ligand 0.41

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HDAC6 Q9UBN7 9/20 0.41
▸ HDAC8 Q9BY41 7/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ HDAC1 Q13547 5/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ MEN1 O00255 1/20 0.37
▸ LMNA P02545 1/20 0.37
▸ ALOX15 P16050 1/20 0.37
▸ ALOX12 P18054 1/20 0.37
▸ RECQL P46063 1/20 0.37
▸ ADAM17 P78536 1/20 0.37
▸ KMT2A Q03164 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ HDAC11 Q96DB2 1/20 0.37
▸ ALOX5 P09917 1/20 0.37
▸ KDM1A O60341 1/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297190 0.89 HDAC6 (0.44) HDAC6HDAC8HDAC3HDAC1KDM4E
SCHEMBL11303497 0.88 HDAC8 (0.46) HDAC6HDAC8HDAC1KDM4EMEN1
SCHEMBL11303321 0.82 HDAC8 (0.44) HDAC6HDAC8HDAC3HDAC1
SCHEMBL11297461 0.80 HDAC8 (0.37) HDAC6HDAC8HDAC3HDAC1KDM4E
SCHEMBL11296626 0.79 HDAC8 (0.49) HDAC8HDAC1KDM4ENPC1RAB9A
SCHEMBL11305647 0.75 HDAC6 (0.41) HDAC6HDAC8HDAC3HDAC1KDM4E
SCHEMBL11299059 0.74 HDAC6 (0.48) HDAC6HDAC8HDAC3HDAC1HDAC11
SCHEMBL11303510 0.72 MEN1 (0.47) MEN1KMT2ARAB9A
SCHEMBL11372589 0.72 HDAC1 (0.48) HDAC6HDAC8HDAC3HDAC1HDAC11
SCHEMBL11301919 0.72 HDAC1 (0.48) HDAC6HDAC8HDAC3HDAC1HDAC11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback